Articles from BIOTECH Patent News (September 1, 2001)

1-38 out of 38 article(s)

Title	Type	Words
3-Dimensional receives patent protection.	Brief Article	262
Aastrom receives patent covering integrated system for producing human cells.	Brief Article	418
Amgen obtains United States patent.	Brief Article	52
Atrix acquires growth promoting peptide.	Brief Article	332
Avant receives patent and acquires additional patents to strengthen intellectual property of Ceti-1 vaccine.	Brief Article	334
Aventis obtains United States patent.	Brief Article	68
AVIVA Biosciences obtains allowance of biochip patent.	Brief Article	269
BioMarin obtains United States patent.	Brief Article	77
Biotechnology Research & Development obtains United States patent.	Brief Article	35
Cambridge Antibody announces grant of antibody patent.	Brief Article	467
Cardiotech and Implant Sciences announce development of unique anti-restenosis stent.	Brief Article	427
Case Western obtains United States patent.	Brief Article	27
CEL-SCI obtains three new HIV patents.	Brief Article	530
Cholesterol-binding peptide licensed to Samaritan by Georgetown.	Brief Article	496
Dannenberg et al. obtains United States patent.	Brief Article	113
Diversa announces issuance of patent reinforcing rights for discovery of enzymes.	Brief Article	257
DNA Plant Technology obtains United States patent.	Brief Article	59
Eli Lilly obtains United States patent.	Brief Article	51
Genelabs obtains United States patent.	Brief Article	29
Genentech obtains United States patent.	Brief Article	19
GPC Biotech announces issuance of 2 patents for anti-fungal.	Brief Article	578
GPI NIL Holdings obtains United States patent.	Brief Article	42
GSF Forshungszentrum obtains United States patent.	Brief Article	40
HemaMetrics wins summary judgment on Delta H.	Brief Article	341
Introgen's anti-cancer therapy in combination with established cancer treatments awarded patent.	Brief Article	482
Jury reaches decision in Boston Scientific stent patent litigation.	Brief Article	247
Lexicon and Deltagen announce settlement.	Brief Article	635
Medigene expands exclusive license for the universal application of herpes simplex virus amplicon technology.		440
Monsanto obtains United States patent.	Brief Article	30
MorphoSys confirms filing of new patent lawsuit by CAT.	Brief Article	450
Nautilus Biotech files directed evolution patent application.	Brief Article	345
Roche obtains United States patent.	Brief Article	65
RTP Pharma enters exclusive injectable alliance With Baxter.	Brief Article	417
Syngenta obtains United States patent.	Brief Article	53
Tangerine and ImClone sign oligonucleotide license agreement.	Brief Article	353
University of Arkansas obtains United States patent.	Brief Article	77
University of California obtains United States patent.	Brief Article	31
University of Wisconsin obtains United States patent.	Brief Article	56